Drugs / TIV
last change May 2012 re-read 2 minutes ago

TIV

Vaccine

Developed for
influenza

Trials 0

Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2/3 NCT00645411 Comparator Oct 2007 → Feb 2008 influenza Novartis Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as TIV ClinicalTrials.gov intervention name — accepted as the source's own label NCT00645411
Modality Vaccine “conventional egg-derived trivalent influenza vaccine (TIV)” PMID 22301476 May 2012